vimarsana.com

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Massachusetts ,Lora Grassilli ,Ted Jenkins ,Sath Shukla ,Exchange Commission ,Administration For Strategic Preparedness ,Health Media Relations ,Development Authority ,Meiji Seika Pharma Co ,Us Department Of Health ,Nasdaq ,Tebipenem Hbr Research ,Human Services ,Biomedical Advanced Research ,Drug Administration ,Zeno Group ,Spero Therapeutics Inc ,Therapeutics Announces First Patient ,First Visit ,Complicated Urinary Tract ,Meiji Seika Pharma ,Qualified Infectious Disease Product ,Fast Track ,Strategic Preparedness ,Relations Contact ,Investor Relations ,Health Media ,

vimarsana.com © 2020. All Rights Reserved.